Health
International trial of blood thinners for COVID-19 treatment begins – News-Medical.Net
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new da…
A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of activ…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News16 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General12 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery